Strategic Partnerships Target OICR as a gateway to Ontario’s cancer research ecosystem. Their collaborative, not-for-profit model and network-building emphasis suggest opportunities for joint grants, data-sharing collaborations, and co-development programs with academic medical centers, government partners, and private sector collaborators.

translational focus Leverage their translational research mandate to offer services that bridge discovery to clinic—clinical trial facilitation, real-world evidence generation, and regulatory science support could be valued as end-to-end solutions for accelerating Bring Discoveries to Patients.

Data and IA OICR emphasizes data sharing and has a track record with genomic and clinical data harmonization (ICGC ARGO). Propose data management, analytics, and AI-enabled research platforms, plus security/compliance frameworks, to enhance their collaborative networks and tooling.

Innovation Funding With government backing and involvement in commercialization via Fight Against Cancer Innovation Trust, present opportunities for funded pilots, technology licensing, and venture-style partnerships that align with Ontario’s economic and healthcare outcomes.

Emerging Therapies Recent news highlights medulloblastoma therapies, blood-brain barrier penetrating compounds, and next-generation oncology medicines. Position capabilities in drug discovery support, preclinical studies, biomarker development, and companion diagnostics to accelerate these programs.